World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
10350
World Ranking
4324
National Ranking
167

Best Publications

  • Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study

    Takashi Ishida;Tatsuro Joh;Naokuni Uike;Kazuhito Yamamoto

  • Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma.

    Junichi Kiyasu;Junichi Kiyasu;Hiroaki Miyoshi;Akie Hirata;Fumiko Arakawa

  • Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma

    Kazuhito Yamamoto;Atae Utsunomiya;Kensei Tobinai;Kunihiro Tsukasaki

  • Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma.

    Michinori Ogura;Takashi Ishida;Kiyohiko Hatake;Masafumi Taniwaki

  • Treatment and survival among 1594 patients with ATL

    Hiroo Katsuya;Kenji Ishitsuka;Atae Utsunomiya;Shuichi Hanada

  • Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma

    Yasushi Yatabe;Ritsuro Suzuki;Kensei Tobinai;Yoshihiro Matsuno

  • Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients.

    R Kihara;Y Nagata;H Kiyoi;T Kato

  • Analysis of Genetic Polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese Patients with Therapy-related Leukemia/Myelodysplastic Syndrome and de novo Acute Myeloid Leukemia

    Tomoki Naoe;Kunihiko Takeyama;Toshiya Yokozawa;Hitoshi Kiyoi

  • Prognostic Index for Acute- and Lymphoma-Type Adult T-Cell Leukemia/Lymphoma

    Hiroo Katsuya;Takeharu Yamanaka;Kenji Ishitsuka;Atae Utsunomiya

  • Identification of the human eosinophil lineage-committed progenitor: revision of phenotypic definition of the human common myeloid progenitor

    Yasuo Mori;Hiromi Iwasaki;Kentaro Kohno;Goichi Yoshimoto

  • Disease evolution and outcomes in familial AML with germline CEBPA mutations

    Kiran Tawana;Jun Wang;Aline Renneville;Aline Renneville;Csaba Bödör

  • Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma

    Takuya Fukushima;Yasushi Miyazaki;S Honda;F Kawano

  • Involvement of interferon‐γ and macrophage colony‐stimulating factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults

    Koichi Akashi;Shin Hayashi;Hisashi Gondo;Shin-ichi Mizuno

  • Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia-lymphoma with special emphasis on preconditioning regimen: a nationwide retrospective study.

    Takashi Ishida;Masakatsu Hishizawa;Koji Kato;Ryuji Tanosaki

  • Bone marrow-derived mesenchymal stem cells (JR-031) for steroid-refractory grade III or IV acute graft-versus-host disease: a phase II/III study

    Kazuo Muroi;Koichi Miyamura;Masaya Okada;Takuya Yamashita

  • Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study

    T. Igarashi;Y. Kobayashi;M. Ogura;T. Kinoshita

  • Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies

    S Ogawa;A Hangaishi;S Miyawaki;S Hirosawa

  • Clinical outcomes of a novel therapeutic vaccine with Tax peptide‐pulsed dendritic cells for adult T cell leukaemia/lymphoma in a pilot study

    Youko Suehiro;Atsuhiko Hasegawa;Tadafumi Iino;Amane Sasada

  • Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era.

    Ritsuko Seki;Koichi Ohshima;Tomoaki Fujisaki;Naokuni Uike

  • Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma.

    Masami Kuniyoshi;Makoto Nakamuta;Hironori Sakai;Munechika Enjoji

Frequent Co-Authors

Atae Utsunomiya
Atae Utsunomiya Kagoshima University
Masafumi Taniwaki
Masafumi Taniwaki Kyoto Prefectural University of Medicine
Yasuo Morishima
Yasuo Morishima Aichi Medical University
Koichi Ohshima
Koichi Ohshima Kurume University
Toshihiro Miyamoto
Toshihiro Miyamoto Kyushu University
Ryuzo Ueda
Ryuzo Ueda Nagoya University
Mari Kannagi
Mari Kannagi Tokyo Medical and Dental University
Koichi Akashi
Koichi Akashi Kyushu University
Masao Seto
Masao Seto Kurume University
Masao Matsuoka
Masao Matsuoka Kumamoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Naokuni Uike